[卢]PSMA - 617放射性核素疗法显示出前景。 - Suppr

Suppr

超能文献

[Lu]PSMA-617 radionuclide therapy shows promise.

作者信息

Bradley Conor A

机构信息

Nature Reviews Urology, .

出版信息

Nat Rev Urol. 2018 Aug;15(8):468. doi: 10.1038/s41585-018-0029-6.

DOI:10.1038/s41585-018-0029-6

PMID:29789593

Abstract

摘要

相似文献

[Lu]PSMA-617 radionuclide therapy shows promise.[卢]PSMA - 617放射性核素疗法显示出前景。

Nat Rev Urol. 2018 Aug;15(8):468. doi: 10.1038/s41585-018-0029-6.

[Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer.[镥]-PSMA-617放射性核素治疗转移性去势抵抗性前列腺癌患者。

Lancet Oncol. 2018 Aug;19(8):e371. doi: 10.1016/S1470-2045(18)30410-8.

[Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer.[镥]-PSMA-617放射性核素疗法治疗转移性去势抵抗性前列腺癌患者

Lancet Oncol. 2018 Aug;19(8):e372. doi: 10.1016/S1470-2045(18)30488-1.

[Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer - Author's reply.[镥]-PSMA-617放射性核素治疗转移性去势抵抗性前列腺癌患者——作者回复

Lancet Oncol. 2018 Aug;19(8):e373. doi: 10.1016/S1470-2045(18)30534-5.

Re: [Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study.回复：[镥]-PSMA-617放射性核素治疗转移性去势抵抗性前列腺癌患者（镥PSMA试验）：一项单中心、单臂、2期研究。

Eur Urol. 2019 Mar;75(3):536-537. doi: 10.1016/j.eururo.2018.11.005. Epub 2018 Nov 15.

[Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?用于靶向治疗前列腺癌的[镥]-PSMA-617：神奇子弹？

Lancet Oncol. 2018 Jun;19(6):725-726. doi: 10.1016/S1470-2045(18)30268-7. Epub 2018 May 8.

Results of a Prospective Phase 2 Pilot Trial of Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression.Lu-PSMA-617 治疗转移性去势抵抗性前列腺癌的前瞻性 2 期试验结果，包括治疗反应的影像学预测因子和进展模式。

Clin Genitourin Cancer. 2019 Feb;17(1):15-22. doi: 10.1016/j.clgc.2018.09.014. Epub 2018 Sep 27.

A perspective on the EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands.

Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2666-2667. doi: 10.1007/s00259-021-05400-5. Epub 2021 May 13.

Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer.Bi-PSMA-617靶向α放射性核素疗法治疗转移性去势抵抗性前列腺癌

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1099-1100. doi: 10.1007/s00259-017-3657-9. Epub 2017 Mar 2.

[44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.[44Sc]Sc-PSMA-617 示踪剂在转移性去势抵抗性前列腺癌患者中的生物分布和剂量学研究。

Clin Nucl Med. 2018 May;43(5):323-330. doi: 10.1097/RLU.0000000000002003.

引用本文的文献

Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability and .靶向 PSMA 的纳米气泡超声对比剂的细胞内囊泡捕获促进了增强和稳定性的延长。

Nanotheranostics. 2022 Feb 14;6(3):270-285. doi: 10.7150/ntno.64735. eCollection 2022.

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook.前列腺特异性膜抗原（PSMA）正电子发射断层扫描（PET）成像在胶质母细胞瘤中的应用：临床前评估与诊疗前景

Front Oncol. 2021 Nov 17;11:774017. doi: 10.3389/fonc.2021.774017. eCollection 2021.

Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management.不断演变的去势抵抗和前列腺特异性膜抗原表达：对患者管理的影响

Cancers (Basel). 2021 Jul 16;13(14):3556. doi: 10.3390/cancers13143556.

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers.光动力疗法：靶向癌症生物标志物用于癌症治疗

Cancers (Basel). 2021 Jun 15;13(12):2992. doi: 10.3390/cancers13122992.

Quality control and GMP synthesis of Ga-prostate-specific membrane antigen-11 for detection of low- and high-grade prostate cancer.用于检测低级别和高级别前列腺癌的镓-前列腺特异性膜抗原-11的质量控制与GMP合成

World J Nucl Med. 2019 Jul 23;19(2):93-98. doi: 10.4103/wjnm.WJNM_82_18. eCollection 2020 Apr-Jun.

Integrin αβ-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy.整合素 αβ 靶向放射性核素治疗联合免疫检查点阻断免疫治疗协同增强抗肿瘤疗效。

Theranostics. 2019 Oct 16;9(25):7948-7960. doi: 10.7150/thno.39203. eCollection 2019.

Radio-enhancement effects by radiolabeled nanoparticles.放射性标记纳米颗粒的放射增敏作用。

Sci Rep. 2019 Oct 4;9(1):14346. doi: 10.1038/s41598-019-50861-2.

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen.用于前列腺癌诊断、成像和治疗的新靶点：聚焦前列腺特异性膜抗原。

Front Oncol. 2018 Dec 21;8:653. doi: 10.3389/fonc.2018.00653. eCollection 2018.

Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine.使用放射性标记的前列腺特异性膜抗原（PSMA）抑制剂对前列腺癌进行靶向α治疗：核医学领域的变革者。

Am J Nucl Med Mol Imaging. 2018 Aug 20;8(4):247-267. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验